Article
A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Oncotarget - 16 Aug 2016
Van Allen Eliezer M, Robinson Dan, Morrissey Colm, Pritchard Colin, Imamovic Alma, Carter Scott, Rosenberg Mara, McKenna Aaron, Wu Yi-Mi, Cao Xuhong, Chinnaiyan Arul, Garraway Levi, Nelson Peter S
Abstract excerpt
Advances in next generation sequencing technologies provide approaches to comprehensively determine genomic alterations within a tumor that occur as a cause or consequence of neoplastic growth. Though providers offering various cancer genomics assays have multiplied, the level of reproducibility in terms of the technical sensitivity and the conclusions resulting from the data analyses have not been assessed.We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
